HP announced on November 5 that it has appointed Emma Walmsley, the former CEO of GSK, as its new CEO.
According to HP, Walmsley's term will begin on January 4, succeeding interim CEO Bruce Broussard, who has led the company since February.
Walmsley has a 17-year tenure at L'Oréal before joining GSK in 2010, where she served as Group CEO from 2017 to 2025. During her time at GSK, she led significant business transformations, including the spin-off of the consumer healthcare division, a focus on pharmaceuticals and vaccines, and revitalizing the research and development pipeline.
She has also been a member of the Microsoft board for the past seven years.
Walmsley stated, "In line with the AI era, we will focus on harnessing creativity and innovation to secure new growth drivers for our customers, shareholders, partners, and employees."
Along with this appointment, the board's governance structure will also be restructured. Bruce Broussard will take over as the new board chair in January, succeeding Chip Berg, who has led the board since 2017 after joining in 2015. Berg will support the transition process for the management team.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.